Navigation Links
XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention
Date:8/26/2008

MENLO PARK, Calif., Aug. 26 /PRNewswire-FirstCall/ -- XTENT, Inc. (Nasdaq: XTNT) today announced that the positive one-year follow-up data from the CUSTOM II trial was published in the most recent issue of the peer-reviewed journal, EuroIntervention. The lead author of the article was Dr. Pieter R. Stella, M.D., of University Medical Center Utrecht, Utrecht, The Netherlands on behalf of the CUSTOM II Investigators from 13 clinical sites across Europe.

The one-year CUSTOM II trial, a single-arm, 100-patient prospective study designed to evaluate the safety and efficacy of XTENT's Custom NX(R) drug-eluting stent (DES) system in patients with coronary artery disease, showed no new major adverse cardiac events (MACE) since the first analysis was performed at six months. The incidence of late stent thrombosis for patients treated with Custom NX in the study was zero percent.

CUSTOM II one-year follow-up results were first presented last year at Cardiovascular Research Foundation's (CRF) nineteenth annual Transcatheter Cardiovascular Therapeutics (TCT) meeting.

"This article marks our second publication of Custom NX data in this prestigious peer-reviewed journal this year," said Gregory D. Casciaro, XTENT's president and CEO. "We have been extremely pleased with the safety and efficacy Custom NX has demonstrated in the CUSTOM I, II and III trials, and appreciate the level of interest and support our technology continues to receive from the clinical community."

Results from the two-year follow-up of CUSTOM I, a 30-patient first-in-man study designed to evaluate the preliminary safety and feasibility of in-situ stent customization, were also published in EuroIntervention earlier this year. This study showed no new majo
'/>"/>

SOURCE XTENT, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. XTENT Announces European Regulatory Update
2. Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
3. XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
4. XTENT Announces Clinical Trial Data to be Presented at Annual EuroPCR Meeting Next Week
5. XTENT Announces First Quarter 2008 Financial Results
6. Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis
7. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
8. XTENT to Present CUSTOM I and CUSTOM II Trial Data at TCT 2007
9. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
10. Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
11. Genmab Announces Upcoming Ofatumumab Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015  In a sweeping analysis assessing the current ... Exchange researchers conclude that there remains considerable room ... all age groups, but especially for adolescents and young ... diabetes treatment, underscoring the need to address barriers to ... help type 1 patients achieve optimal metabolic control. ...
(Date:5/22/2015)... 22, 2015  China Nepstar Chain Drugstore Ltd. (NYSE: ... drugstore chain in China based ... the resignation of Mr. Fuxiang Zhang as ... immediately. Ms. Rebecca Yingnan Zhang has been ... of directors, effective immediately. Meanwhile, Ms. Zhang resigned from ...
(Date:5/21/2015)... 21, 2015 Research and ... of the "North American Active Wound Care ... (Surgical Wound, & Ulcer), by End-User (In-Patient, & ... report to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... estimated to grow at a CAGR of 3.1% ...
Breaking Medicine Technology:Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2
... Waltham, Mass., June 7, 2007 – Dynogen Pharmaceuticals,Inc. ... 1b trial of DDP733 for gastroesophageal,reflux disease (GERD). ... DDP733 as a treatment for nocturnal GERD,(NGERD). ... statistical,significance over placebo on the primary endpoint of ...
... 2007 - AVANIR,Pharmaceuticals (NASDAQ:AVNR) today announced ... efficacy, safety and improvements in,patient-centered outcomes ... pain treated with the investigational drug,Zenvia(TM) ... sigma-1 agonist. The data were accepted ...
Cached Medicine Technology:Dynogen's DDP733 Reduces Reflux in Phase 1b GERD Study 2Dynogen's DDP733 Reduces Reflux in Phase 1b GERD Study 3AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 2AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 3AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 4AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 5AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 6AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 7
(Date:5/26/2015)... Foot and Ankle Specialists of ... Leone (Pasadena and Baltimore Divisions) was recently presented ... Medical Association (MPMA) President from 2013 to 2015 at ... Doctorate in Podiatric Medicine from Temple University in 1999 ... in Voorhees, New Jersey. Dr. Leone is an ...
(Date:5/26/2015)... 2015 Pacifica Graduate Institute ... Memorial Day weekend, celebrating the outstanding accomplishments of ... picturesque Ladera Lane campus, located in the Santa ... traveled to Santa Barbara from all over the ... , The 2015 commencement ceremonies featured the traditional ...
(Date:5/26/2015)... The Brain Aneurysm Foundation is proud ... their renowned Conductor Keith Lockhart will once again team ... 10, 2015—the 4th Annual Brain Aneurysm Foundation Night ... is set to feature an exclusive Brain Aneurysm Foundation ... who tragically lost his sister-in-law to a brain aneurysm ...
(Date:5/26/2015)... 26, 2015 The professionals from Marietta ... it again, helping local rescue pets with a parking ... dentists, Kirk Kimmerling DDS, Suzanna Aguilera DMD and Garrick ... DVM donating 100% of proceeds from the extravaganza. , ... parking lot to help save unwanted, local animals. ...
(Date:5/26/2015)... Pinehurst, NC (PRWEB) May 26, 2015 ... otolaryngologists at Pinehurst Surgical Center in Pinehurst, N.C. have ... area sinus surgery patients about chronic sinusitis and the ... questionnaire that can be used to determine if someone ... asks questions about symptoms and other factors that can ...
Breaking Medicine News(10 mins):Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Podiatrist Receives MPMA Service Award 2Health News:Pacifica Graduate Institute Hosted its 2015 Commencement Ceremonies over Memorial Day Weekend 2Health News:Pacifica Graduate Institute Hosted its 2015 Commencement Ceremonies over Memorial Day Weekend 3Health News:Boston Pops & Renowned Conductor Keith Lockhart to Join the Brain Aneurysm Foundation for the 4th Annual Brain Aneurysm Foundation Night at the Pops 2Health News:"Rescue Animal Cookout" Announced at Verde Pointe Professional Park on June 25, 2015 2Health News:Pinehurst Surgical Sinus Center Launches Pinehurst Balloon Sinuplasty Website 2
... , SANTA FE, N.M., Aug. 13 The New ... a new alliance to assist school districts with Medicaid claiming. This ... and will be administered by Accelify. , , ... NMSBA,s Executive Director. "NMSBA is focused on bringing value-added programs to ...
... 13 Select Medical Corporation ("Select") today announced results for ... For the second quarter ended June 30, 2009, ... $538.8 million for the same quarter, prior year. Income ... million for the same quarter, prior year. Net income ...
... , IRVINE, Calif., Aug. 13 ... used in the treatment of patients suffering from severe angina, today ... , , Net revenues in the second quarter ... second quarter net revenues of $4,119,000. The decrease in net ...
... Rheumatoid arthritis pain subsided when depression and inflammation ... -- Treating both depression and inflammation can reduce ... Japanese researchers say. , They studied 218 RA ... depression symptoms, year of RA onset, smoking and ...
... SAN JOSE, Calif., Aug. 13 Human Pheromone Sciences, Inc. ... the three and six months ended June 30, 2009. For the three ... 5% decrease from the revenues of $236,000 in the prior year period, ... compared with a net loss of $88,000 ($0.02 per share) for the ...
... , , NEW YORK, Aug. 13 ... to fight obesity and its consequences. Chef Lindsey Williams, grandson of ... author of " Neo Soul ," a collection of traditional soul food ... a series of breakfast smoothies named after iconic Harlem figures this weekend ...
Cached Medicine News:Health News:New Mexico School Boards Association and Accelify Announce Alliance to Assist New Mexico Schools 2Health News:Select Medical Corporation Announces Results for Second Quarter Ended June 30, 2009 2Health News:Select Medical Corporation Announces Results for Second Quarter Ended June 30, 2009 3Health News:Select Medical Corporation Announces Results for Second Quarter Ended June 30, 2009 4Health News:Select Medical Corporation Announces Results for Second Quarter Ended June 30, 2009 5Health News:Select Medical Corporation Announces Results for Second Quarter Ended June 30, 2009 6Health News:Select Medical Corporation Announces Results for Second Quarter Ended June 30, 2009 7Health News:Select Medical Corporation Announces Results for Second Quarter Ended June 30, 2009 8Health News:Select Medical Corporation Announces Results for Second Quarter Ended June 30, 2009 9Health News:Select Medical Corporation Announces Results for Second Quarter Ended June 30, 2009 10Health News:Select Medical Corporation Announces Results for Second Quarter Ended June 30, 2009 11Health News:Select Medical Corporation Announces Results for Second Quarter Ended June 30, 2009 12Health News:Select Medical Corporation Announces Results for Second Quarter Ended June 30, 2009 13Health News:Select Medical Corporation Announces Results for Second Quarter Ended June 30, 2009 14Health News:Select Medical Corporation Announces Results for Second Quarter Ended June 30, 2009 15Health News:Cardiogenesis Reports Second Quarter 2009 Results 2Health News:Cardiogenesis Reports Second Quarter 2009 Results 3Health News:Cardiogenesis Reports Second Quarter 2009 Results 4Health News:Cardiogenesis Reports Second Quarter 2009 Results 5Health News:Cardiogenesis Reports Second Quarter 2009 Results 6Health News:Cardiogenesis Reports Second Quarter 2009 Results 7Health News:Treat Mind, Body in RA Patients: Study 2Health News:Human Pheromone Sciences Announces Second Quarter Results 2Health News:Human Pheromone Sciences Announces Second Quarter Results 3Health News:Human Pheromone Sciences Announces Second Quarter Results 4Health News:Queen of Soul Food's Grandson on Mission to Get Harlem Kids to Eat Healthier 2Health News:Queen of Soul Food's Grandson on Mission to Get Harlem Kids to Eat Healthier 3
Inquire...
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
This is a single-action instrument that features a spring handle....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
Medicine Products: